Ex Parte Mydlarz et al - Page 5




               Appeal No. 2004-1835                                                                          Page 5                 
               Application No. 09/919,118                                                                                           


               Boesch, 617 F.2d 272, 276, 205 USPQ 215, 219 (CCPA 1980).  Note also In re Woodruff, 919 F.2d                        
               1575, 1578, 16 USPQ2d 1934, 1936-37 (Fed. Cir. 1990), and In re Aller, 220 F.2d 454, 456, 105                        
               USPQ 233, 235 (CCPA 1955).                                                                                           
                       Appellants also argue that we erred in determining that their objective evidence of                          
               nonobviousness is not commensurate in scope with the claims (Request, pp. 3-4).  This is because,                    
               according to Appellants, the classes of dopants involved are themselves reasonably well known in                     
               the art, as are their individual performance attributes, as illustrated by the disclosures of the cited              
               prior art references.  Therefore, according to Appellants, multiple examples are not required to                     
               demonstrate individual effects (Request, p. 4).                                                                      
                       Appellants’ data is directed to the LIK performance of the emulsions.  What the prior art                    
               indicates is that the claimed classes of dopants were known to affect speed and contrast, there is no                
               discussion in the references with regard to an effect, as a class, on LIK performance.  Nor have                     
               Appellants provided evidence that LIK performance is affected predictably within the classes.  By                    
               their nature, unexpected and surprising results are unpredictable.  We emphasize that the burden is                  
               on Appellants to show that the results are unexpected for the full range of the combinations of the                  
               classes of dopants claimed.  We agree that, in some instances, the probative value of a narrow range                 
               of data can be reasonably extended to prove the unobviousness of a broader claimed range.  See In                    
               re Kollman, 595 F.2d 48, 56, 201 USPQ 193, 199 (CCPA 1979).  For instance, the probative value                       
               may be extended when one of ordinary skill in the art could ascertain a trend in the exemplified                     
               data.  Id.  Here, the comparison of one combination of dopants within the broad formulas of claim 1                  







Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007